APA (7th ed.) Citation

D, L., F, C., Y, S., & RB, P. (2026). Potential Impact of Prenatal Expanded Carrier Screening on the Incidence of Duchenne Muscular Dystrophy in Neonates. Fetal diagnosis and therapy, 53(2), 133. https://doi.org/10.1159/000548968

Chicago Style (17th ed.) Citation

D, Lanehart, Coyne F, Sheldon Y, and Parad RB. "Potential Impact of Prenatal Expanded Carrier Screening on the Incidence of Duchenne Muscular Dystrophy in Neonates." Fetal Diagnosis and Therapy 53, no. 2 (2026): 133. https://doi.org/10.1159/000548968.

MLA (9th ed.) Citation

D, Lanehart, et al. "Potential Impact of Prenatal Expanded Carrier Screening on the Incidence of Duchenne Muscular Dystrophy in Neonates." Fetal Diagnosis and Therapy, vol. 53, no. 2, 2026, p. 133, https://doi.org/10.1159/000548968.